Cambridge-based AVEO Pharmaceuticals Files to Raise $91-105M: They have JOBS!
0 followers
0 Likes
From New England Tech Wire | Feb 24, 2010
Cambridge, Mass. – AVEO Pharmaceuticals, a Cambridge-based developer of cancer drugs, has filed with the Securities and Exchange Commission for its initial public offering to raise between $91 million and $105 million. Founded in 2002, AVEO is focused on discovering, developing and commercializing new cancer drugs directed against important mechanisms, or targets, known or believed to be involved in cancer. Its lead product candidate is an oral inhibitor of the vascular endothelial growth factor. The company currently plans to sell 7 million shares of common stock priced at between $13 and $15 in its IPO.
http://www.aveopharma.com/
0 Replies
Reply
Subgroup Membership is required to post Replies
Join Better Jobs Faster now
Suggested Posts
| Topic | Replies | Likes | Views | Participants | Last Reply |
|---|---|---|---|---|---|
| Be Self-Employed Writing Content | 0 | 0 | 308 | ||
| Work from Home Writing Articles | 0 | 0 | 136 | ||
| Band Together Seeks New Executive Director in Raleigh Area | 0 | 0 | 541 |